SAN DIEGO, Feb. 8, 2018 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, will participate in the Leerink Partners 7th Annual Global Healthcare Conference in New York on Thursday, February 15th at 2:30 p.m. ET/ 11:30 a.m….
